Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radek Spisek

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Expert Review of Anticancer Therapy|December 22, 2006
Immunoprevention of cancer: time to reconsider timing of vaccination against cancerRadek Spisek
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cellsRadek Spisek, Madhav V Dhodapkar
Hematology/Oncology Clinics of North America|June 10, 2006
Immunoprevention of cancerRadek Spisek, Madhav V Dhodapkar
Transfusion|January 10, 2006
Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host diseaseRadek Spisek, Zdena Gasova, Jirina Bartunkova
Clinical Immunology (Orlando, Fla.)|June 13, 2006
Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptorsDaniela Rozkova, Rudolf Horvath, Jirina Bartunkova, et al.
Cell Research|August 1, 2020
Calreticulin and cancerJitka Fucikova, Radek Spisek, Guido Kroemer, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinomaIva Truxova, David Cibula, Radek Spisek, et al.
Oncoimmunology|February 1, 2020
Calreticulin arms NK cells against leukemiaJitka Fucikova, Justin P Kline, Lorenzo Galluzzi, et al.
Frontiers in Immunology|November 19, 2019
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical ApplicationsJitka Fucikova, Lenka Palova-Jelinkova, Jirina Bartunkova, et al.
Oncoimmunology|December 15, 2018
Tumour devascularisation as a potential immunotherapeutic strategyTomas Buchler, Pavel Vasek, Radek Spisek, et al.
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Expert Review of Anticancer Therapy|December 22, 2006
Immunoprevention of cancer: time to reconsider timing of vaccination against cancerRadek Spisek
Cell Cycle (Georgetown, Tex.)|August 28, 2007
Towards a better way to die with chemotherapy: role of heat shock protein exposure on dying tumor cellsRadek Spisek, Madhav V Dhodapkar
Hematology/Oncology Clinics of North America|June 10, 2006
Immunoprevention of cancerRadek Spisek, Madhav V Dhodapkar
Transfusion|January 10, 2006
Maturation state of dendritic cells during the extracorporeal photopheresis and its relevance for the treatment of chronic graft-versus-host diseaseRadek Spisek, Zdena Gasova, Jirina Bartunkova
Clinical Immunology (Orlando, Fla.)|June 13, 2006
Glucocorticoids severely impair differentiation and antigen presenting function of dendritic cells despite upregulation of Toll-like receptorsDaniela Rozkova, Rudolf Horvath, Jirina Bartunkova, et al.
Cell Research|August 1, 2020
Calreticulin and cancerJitka Fucikova, Radek Spisek, Guido Kroemer, et al.
Journal for Immunotherapy of Cancer|February 23, 2023
Targeting tumor-associated macrophages for successful immunotherapy of ovarian carcinomaIva Truxova, David Cibula, Radek Spisek, et al.
Oncoimmunology|February 1, 2020
Calreticulin arms NK cells against leukemiaJitka Fucikova, Justin P Kline, Lorenzo Galluzzi, et al.
Frontiers in Immunology|November 19, 2019
Induction of Tolerance and Immunity by Dendritic Cells: Mechanisms and Clinical ApplicationsJitka Fucikova, Lenka Palova-Jelinkova, Jirina Bartunkova, et al.
Oncoimmunology|December 15, 2018
Tumour devascularisation as a potential immunotherapeutic strategyTomas Buchler, Pavel Vasek, Radek Spisek, et al.
Pageof 9